PBT 0.00% 0.0¢ prana biotechnology limited

Voyager reports 1b Parkinson's progress, page-5

  1. 3,630 Posts.
    lightbulb Created with Sketch. 116
    Maybe it is the danger that the long term toxicity tests which crashed PBT2 are still to be done alongside the Phase2 PBT434 trial as far as I know. Correct me if I am wrong.

    Do the pharma's think they can develop their own chelators? There are some other MPAC's around and the lead Prana had has possibly been reeled in during 4 years of no clinical progress. 



 
watchlist Created with Sketch. Add PBT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.